Fred R. Hirsch Discusses His Own Cancer Diagnosis

Fred R. Hirsch

Fred R. Hirsch, from the University of Colorado and IASLC, discusses some of the unique challenges he faced as a patient.

Fred R. Hirsch, professor of medicine, professor in pathology, University of Colorado, CEO, International Associate for the Study of Lung Cancer (IASLC), discusses some of the unique challenges he faced as a patient.

When Hirsch was diagnosed with lymphoma, he had been practicing medical oncology for 20 years. Before that moment, Hirsch admits, he thought he knew everything about cancer and cancer treatment. Then, new perspectives came flooding in.

Related Content:

CURE TVLymphoma Cancer
Learning to Live with an Incurable, Inoperable Cancer
‘Incredible’ That a One-Time Infusion of CAR-T Cell Therapy Induces Durable Responses in Acute Lymphoblastic Leukemia
Novel Triplet Combination Shows ‘Notable Efficacy in a Challenging to Treat’ Population of Relapsed/Refractory Diffuse Large B-Cell Lymphoma